Hyaluronic acid-engineered Bcl-2 inhibitor nanocrystals for site-specific delivery to breast tumor cells

被引：3
|
作者：
Panwar, Dilip [1 ]
Thakor, Pradip [1 ]
Sharma, Madhu [2 ]
Bakshi, Avijit Kumar [2 ]
Bhavana, Valamla [1 ]
Srivastava, Vaibhavi [1 ]
Mishra, Prabhat Ranjan [2 ]
Singh, Shashi Bala [3 ]
Mehra, Neelesh Kumar [1 ]
机构：
[1] Natl Inst Pharmaceut Educ & Res NIPER, Dept Pharmaceut, Pharmaceut Nanotechnol Res Lab, Hyderabad 500037, Telangana, India
[2] Council Sci & Ind Res Cent Drug Res Inst CSIR CDRI, Div Pharmaceut, Lucknow 226017, Uttar Pradesh, India
[3] Natl Inst Pharmaceut Educ & Res NIPER, Dept Biol Sci, Hyderabad 500037, Telangana, India
来源：
NANOMEDICINE | 2023年 / 18卷 / 15期
关键词：
breast cancer; glycosaminoglycan; hyaluronic acid; nanocrystals; repurposing; venetoclax; DRUG-DELIVERY; NANOPARTICLES; DOXORUBICIN; PACLITAXEL; PH;
D O I：
10.2217/nnm-2023-0132
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Aim: This investigation aims to repurpose venetoclax using hyaluronic acid-coated venetoclax nanocrystals (HA-VEN-NCs) to target breast cancer. Materials & methods: An antisolvent precipitation method was used to fabricate the nanocrystals and optimize them using central composite design. Hyaluronic acid (HA)-coated and -uncoated nanocrystals were compared in terms of in vitro drug release, cell line studies, CD44-expressing breast tumor cell binding capability and anticancer activity. Results: HA-VEN-NCs and venetoclax nanocrystals (VEN-NCs) showed pH-responsive drug-release behavior, exhibiting sustained release at pH 6.8. Our extensive in vitro cell line investigation showed that HA-VEN-NCs efficiently bind to CD44-expressing breast tumor cells and possess excellent anticancer activity (half maximal inhibitory concentration: 2.00 & mu;g/ml) compared with VEN-NCs. Conclusion: Our findings anticipate that HA-VEN-NCs could serve as valuable nanoplatforms for cancer treatments in the future.
引用
收藏
页码：1005 / 1023
页数：19
相关论文
共 50 条
  • [31] Improved Pharmacokinetic and Biodistribution Properties of the Selective Urokinase Inhibitor PAI-2 (SerpinB2) by Site-Specific PEGylation: Implications for Drug Delivery
    Vine, Kara Lea
    Lobov, Sergei
    Chandran, Vineesh Indira
    Harris, Nathanial Lachlan Ewart
    Ranson, Marie
    PHARMACEUTICAL RESEARCH, 2015, 32 (03) : 1045 - 1054
  • [32] Improved Pharmacokinetic and Biodistribution Properties of the Selective Urokinase Inhibitor PAI-2 (SerpinB2) by Site-Specific PEGylation: Implications for Drug Delivery
    Kara Lea Vine
    Sergei Lobov
    Vineesh Indira Chandran
    Nathanial Lachlan Ewart Harris
    Marie Ranson
    Pharmaceutical Research, 2015, 32 : 1045 - 1054
  • [33] RETRACTED: Molecular mechanisms involved in resistance of CLL cells towards ABT-737, a specific BCL-2 inhibitor (Retracted Article)
    Sun, Xiao-Ming
    Dyer, Martin J.
    Cohen, Gerald. M.
    TOXICOLOGY, 2011, 290 (2-3) : 111 - 111
  • [34] BM-1252 (APG-1252): a potent dual specific Bcl-2/Bcl-xL inhibitor that achieves complete tumor regression with minimal platelet toxicity
    Bai, L.
    Chen, J.
    Liu, L.
    McEachern, D.
    Aguilar, A.
    Zhou, H.
    Yang, C. Y.
    Wang, H.
    Wen, J.
    Wang, G.
    Zhai, Y.
    Guo, M.
    Yang, D.
    Wang, S.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 109 - 110
  • [35] Ionizing Radiation Sensitizes Breast Cancer Cells to Bcl-2 Inhibitor, ABT-737, through Regulating Mcl-1
    Wu, Hao
    Schiff, Devora S.
    Lin, Yong
    Neboori, Hanmanth J. R.
    Goyal, Sharad
    Feng, Zhaohui
    Haffty, Bruce G.
    RADIATION RESEARCH, 2014, 182 (06) : 618 - 625
  • [36] TRANSFER OF THE TUMOR-NECROSIS-FACTOR-ALPHA GENE INTO HEMATOPOIETIC PROGENITOR CELLS AS A MODEL FOR SITE-SPECIFIC CYTOKINE DELIVERY AFTER MARROW TRANSPLANTATION
    KUHR, T
    DOUGHERTY, GJ
    KLINGEMANN, HG
    BLOOD, 1994, 84 (09) : 2966 - 2970
  • [37] Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells
    Lima, RT
    Martins, SM
    Guimaraes, JE
    Sambade, C
    Vasconcelos, MH
    CANCER GENE THERAPY, 2004, 11 (05) : 309 - 316
  • [38] Polylactic Acid-Based Patterned Matrixes for Site-Specific Delivery of Neuropeptides On-Demand: Functional NGF Effects on Human Neuronal Cells
    Sindeeva, Olga A.
    Kopach, Olga
    Kurochkin, Maxim A.
    Sapelkin, Andrei
    Gould, David J.
    Rusakov, Dmitri A.
    Sukhorukov, Gleb B.
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2020, 8 (08):
  • [39] Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells
    Raquel T Lima
    Luís M Martins
    José E Guimarães
    Clara Sambade
    M Helena Vasconcelos
    Cancer Gene Therapy, 2004, 11 : 309 - 316
  • [40] Site-Specific Conjugation of Auristatins onto Engineered scFv Using Second Generation Maleimide to Target HER2-positive Breast Cancer in Vitro
    Aubrey, Nicolas
    Allard-Vannier, Emilie
    Martin, Camille
    Bryden, Francesca
    Letast, Stephanie
    Colas, Cyril
    Lakhrif, Zineb
    Collinet, Nils
    Pimier-Poisson, Isabelle
    Chourpa, Igor
    Viaud-Massuard, Marie-Claude
    Joubert, Nicolas
    BIOCONJUGATE CHEMISTRY, 2018, 29 (11) : 3516 - 3521
12345